Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001415889-25-023791

CHIEF EXECUTIVE OFFICER acquired 90,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Seehra Jasbir CHIEF EXECUTIVE OFFICER 2025-09-03 Grant or award +90,500 392,723 D
Loading xslF345X05/form4-09052025_040903.xml…